Promaxo | Top Medical Imaging Solutions Company 2023
Healthcare Tech Outlook
>> >>

Promaxo
MRI Guided Interventions in a Physician’s Office

MRI Guided Interventions in a Physician’s Office

Amit Vohra, Promaxo | Healthcare Tech Outlook | Top Medical Imaging Solutions CompaniesAmit Vohra, Founder, President, and CEO, Promaxo
Promaxo, an innovative leader in the med tech space, is revolutionizing patient care with its MRI targeted interventions in office-based care settings. Founded by a team of entrepreneurs and healthcare innovators, Promaxo has developed a patient-centric MRI and robotic platform that is redefining the standard of care. Based in the San Francisco Bay Area and backed by over 200 patents, the Company is committed to improving lives through state-of-theart medical imaging, robotics, and AI capabilities.

Promaxo's compact and adaptable MRI system was created to improve the quality and speed of patient diagnosis and interventions. Unlike traditional MRI systems, which are often inconvenient and inaccessible, Promaxo's portable MRI systems can be easily placed inside a physician’s office or clinic without additional facility upgrades. The singlesided, minimally invasive, and entirely open MRI is designed to be patient-friendly by eliminating the need for a gantry, which alleviates patient concerns of claustrophobia. Moreover, patients are at ease with the minimally invasive approach when using Promaxo MRI to guide a targeted procedure.

“Our MRI System combines proprietary technologies to pack advanced medical imaging and live navigation into a compact design with zero compromise in the quality of clinical outcomes,” says Amit Vohra, Founder, President, and CEO of Promaxo.

The Promaxo MRI currently operates to address prostate cancer in a clinic or ambulatory surgical setting, and is poised to enter parallel and adjacent markets, such as women’s urology, gynecology, and more.

As outpatient procedures move out of hospital settings and into offices or ASCs, Promaxo is well-equipped to accelerate this transition, creating a pathway that better manages a patient's care journey. Promaxo’s MRI targeted prostate biopsy approach demonstrates a higher cancer detection rate, along with the ability to upstage the final diagnosis using significantly fewer tissue samples as compared to the standard-of-care systematic transrectal ultrasound-guided prostate biopsy.

Promaxo's success has enabled patients to adopt a more appropriate course of action through earlier detection of prostate cancer, resulting in an improved quality of life and cost savings for those who opt for immediate treatment. The Company's technology pipeline is aligned to its mission - making life easier for patients and physicians by using AI to enhance the images and facilitate a seamless care pathway. Promaxo’s procedural data and images of the patient will enable the Company to build AI-based tissue characterization algorithms in the future, enabling advanced computer-aided diagnostics and successful treatments to complete the full patient care pathway of screening, diagnosis, and treatment.


Our MRI System combines proprietary technologies to pack advanced medical imaging and live navigation into a compact design with zero compromise in the quality of clinical outcomes

From a physician’s perspective, the Promaxo MRI is user-friendly and can be operated without any specialized training. All imaging sequences have been automated and optimized to run with the press of a single button.

The Promaxo MRI creates a comfortable experience for patients and affordable MRI scanners for physicians, resonating with its vision of improving the quality and speed of healthcare delivery, while propelling medical technology further into the future. With its early success and commitment to innovation, Promaxo is set to become the global leader in the med tech space, improving patient care and driving healthcare forward by leaps and bounds.

Top 10 Medical Imaging Solutions Companies - 2023

Company
Promaxo

Management
Amit Vohra, Founder, President, and CEO, Promaxo

Description
Promaxo is a medical technology company that develops and commercializes customer-centric MRI systems and MRI-based technologies that enhance the patient’s life and redefine the standard of care.

Promaxo News

Promaxo Appoints Chad Zaring, Chief Commercial Officer, and Matt Collins, Vice President of Marketing

OAKLAND - Promaxo, Inc., announced today that it has expanded its sales and marketing organization with the appointment of Chad Zaring as Chief Commercial Officer and Matt Collins as Vice President of Marketing.
“We are excited to welcome Chad and Matt to our commercial team, with their skills and experience expected to be immediately accretive, particularly given the continued strong momentum in our operations,” said Dr. Amit Vohra, Founder and CEO of Promaxo. “With our sales pipeline robust, we look forward to continuing healthy growth and steady market penetration of our single sided MR system.”
Chad Zaring possesses over two decades of experience in the industry, demonstrating a consistent history of driving positive business outcomes through the integration of disruptive technologies. His leadership has been evident in pivotal sales and marketing roles at reputable enterprises such as Intuitive Surgical (ISRG) and Mazor Robotics (which was later acquired by Medtronic). During his tenure as the Chief Commercial Officer at Momentis Surgical, Zaring assumed accountability for steering the successful market entry of the firm's robotic surgery platform. Prior to this, he held the position of District Manager at Ethicon Endo-Surgery—an affiliate of Johnson & Johnson. Furthermore, his background includes a role as a urology sales representative at Merck and Co., Inc.
Matt Collins boasts a proven history of introducing revolutionary medical advancements to the market. In his most recent post at Medtronic, he led the triumphant launch of the HugoTM Robotic Assisted Surgery System. Collins is a distinguished alumnus of the University of Notre Dame - Mendoza College of Business, where he earned his MBA. His academic journey also includes the acquisition of a bachelor's degree from the University of Michigan.